Clinical Trials Browser

Terminated × pazopanib × Thoracic × Clear all

Carcinoma, Non-Small-Cell Lung

NCT01392352 2020-02-13

HYPAZ

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Gastrointestinal Neoplasms, Glioblastoma, Hypertension, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Small Cell Lung Carcinoma

NCT01012362 2017-12-28

Study of Pazopanib and Ixabepilone in Patients With Solid Tumors

Phase 1 Terminated

31 enrolled 12 charts

BreastGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Breast Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Sarcoma

NCT00549328 2014-11-19

Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer

Phase 2 Terminated

14 enrolled 5 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01049776 2014-09-19

GW786034 in Patients With Non Small Cell Lung Cancer 3rd Line

Phase 2 Terminated

32 enrolled 7 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01060514 2013-10-30

Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer

Phase 1 Terminated

8 enrolled

BreastThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Clinical Trials

Pazopanib in Molecularly Selected Patients With Advanced NSCLC

HYPAZ

Study of Pazopanib and Ixabepilone in Patients With Solid Tumors

Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer

GW786034 in Patients With Non Small Cell Lung Cancer 3rd Line

Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer